Leila Su

1.2k total citations
19 papers, 851 citations indexed

About

Leila Su is a scholar working on Molecular Biology, Oncology and Inorganic Chemistry. According to data from OpenAlex, Leila Su has authored 19 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Inorganic Chemistry. Recurrent topics in Leila Su's work include Metal-Catalyzed Oxygenation Mechanisms (6 papers), Metal complexes synthesis and properties (5 papers) and RNA modifications and cancer (5 papers). Leila Su is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (6 papers), Metal complexes synthesis and properties (5 papers) and RNA modifications and cancer (5 papers). Leila Su collaborates with scholars based in United States, Taiwan and China. Leila Su's co-authors include Hongfeng Yuan, Wenyong Chen, Yun Yen, Shiuan Chen, Masatomo Suetsugi, Yate‐Ching Yuan, Bingsen Zhou, Shuya Hu, James T. Radek and Michael A. Weiss and has published in prestigious journals such as Journal of Clinical Investigation, Genes & Development and Biochemistry.

In The Last Decade

Leila Su

19 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Su United States 14 514 183 161 160 100 19 851
Susan Cornell-Kennon United States 12 707 1.4× 138 0.8× 62 0.4× 304 1.9× 27 0.3× 21 1.1k
Olesya A. Ulanovskaya United States 15 636 1.2× 134 0.7× 42 0.3× 139 0.9× 76 0.8× 18 925
Michel Tarpin France 11 235 0.5× 114 0.6× 69 0.4× 69 0.4× 62 0.6× 18 515
Midori Shimada Japan 22 1.3k 2.6× 415 2.3× 138 0.9× 183 1.1× 8 0.1× 75 1.7k
Salisha Hill United States 16 630 1.2× 170 0.9× 36 0.2× 145 0.9× 86 0.9× 24 939
Elżbieta Speina Poland 19 832 1.6× 172 0.9× 78 0.5× 288 1.8× 6 0.1× 27 1.1k
Juan I. Garaycoechea United Kingdom 13 969 1.9× 160 0.9× 143 0.9× 323 2.0× 11 0.1× 16 1.4k
Yuyin Li China 21 617 1.2× 284 1.6× 38 0.2× 119 0.7× 14 0.1× 50 984
Kin Chan Hong Kong 19 1.1k 2.2× 277 1.5× 291 1.8× 551 3.4× 7 0.1× 38 1.6k
Elena Beltrami Italy 11 959 1.9× 319 1.7× 48 0.3× 136 0.8× 16 0.2× 15 1.2k

Countries citing papers authored by Leila Su

Since Specialization
Citations

This map shows the geographic impact of Leila Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Su more than expected).

Fields of papers citing papers by Leila Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Su. The network helps show where Leila Su may publish in the future.

Co-authorship network of co-authors of Leila Su

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Su. A scholar is included among the top collaborators of Leila Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Su. Leila Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Keqiang, Jinghan Wang, Jinhui Wang, et al.. (2019). LKB1 deficiency promotes proliferation and invasion of glioblastoma through activation of mTOR and focal adhesion kinase signaling pathways.. American Journal of Cancer Research. 9(8). 1650–1663. 12 indexed citations
2.
Su, Leila, Jianghai Wang, Weizhen Ji, et al.. (2018). A homozygous variant in RRM2B is associated with severe metabolic acidosis and early neonatal death. European Journal of Medical Genetics. 62(11). 103574–103574. 4 indexed citations
3.
Su, Leila, Lijun Xue, Frank Luh, et al.. (2017). Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Carcinogenesis. 38(5). 519–531. 94 indexed citations
4.
Tang, Michelle, Willem den Besten, Shuya Hu, et al.. (2016). PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress. Scientific Reports. 6(1). 18846–18846. 60 indexed citations
5.
Guan, Min, Leila Su, Yate‐Ching Yuan, Haiqing Li, & Warren Chow. (2015). Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer. Scientific Reports. 5(1). 9698–9698. 43 indexed citations
6.
Chen, Mei-Chuan, Bingsen Zhou, Keqiang Zhang, et al.. (2015). The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro. Molecular Pharmacology. 87(6). 996–1005. 23 indexed citations
7.
Zhang, Keqiang, Jia‐Wei Lin, Jinhui Wang, et al.. (2014). A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis. Genetics in Medicine. 16(10). 787–792. 15 indexed citations
8.
Zhou, Bingsen, Leila Su, Shuya Hu, et al.. (2013). A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance. Cancer Research. 73(21). 6484–6493. 65 indexed citations
9.
Otto‐Duessel, Maya, Miaoling He, Leila Su, et al.. (2013). Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium. ACS Chemical Biology. 9(3). 692–702. 46 indexed citations
10.
Chen, Wenyong, Hongfeng Yuan, & Leila Su. (2013). The emerging and diverse roles of sirtuins in cancer: a clinical perspective. OncoTargets and Therapy. 6. 1399–1399. 138 indexed citations
11.
Sakurai, Nagisa, Manami Maeda, Sung‐Uk Lee, et al.. (2011). The LRF transcription factor regulates mature B cell development and the germinal center response in mice. Journal of Clinical Investigation. 121(7). 2583–2598. 39 indexed citations
12.
Zhou, Bingsen, Leila Su, Yate‐Ching Yuan, et al.. (2010). Structural Basis on the Dityrosyl-Diiron Radical Cluster and the Functional Differences of Human Ribonucleotide Reductase Small Subunits hp53R2 and hRRM2. Molecular Cancer Therapeutics. 9(6). 1669–1679. 8 indexed citations
13.
Smith, Peter A., Bingsen Zhou, N.N. Ho, et al.. (2009). 2.6 Å X-ray Crystal Structure of Human p53R2, a p53-Inducible Ribonucleotide Reductase,. Biochemistry. 48(46). 11134–11141. 30 indexed citations
14.
Shao, Jimin, Bingsen Zhou, Lijun Zhu, et al.. (2005). Characterization of the interacting mechanisms between Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and the small subunits of human Ribonucleotide Reductase. Cancer Research. 65. 969–969. 2 indexed citations
15.
Shao, Jimin, Bingsen Zhou, Lijun Zhu, et al.. (2005). Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Biochemical Pharmacology. 69(4). 627–634. 31 indexed citations
16.
Zhou, Bingsen, Jimin Shao, Leila Su, et al.. (2005). A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases. Molecular Cancer Therapeutics. 4(12). 1830–1836. 12 indexed citations
17.
Suetsugi, Masatomo, et al.. (2003). Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.. PubMed. 1(13). 981–91. 146 indexed citations
18.
Su, Leila, James T. Radek, Klaas Hallenga, et al.. (1997). An RNA enhancer in a phage transcriptional antitermination complex functions as a structural switch. Genes & Development. 11(17). 2214–2226. 26 indexed citations
19.
Su, Leila, et al.. (1997). RNA Recognition by a Bent α-Helix Regulates Transcriptional Antitermination in Phage λ. Biochemistry. 36(42). 12722–12732. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Cornell-Kennon Breakdown of academic impact, for papers by Olesya A. Ulanovskaya Breakdown of academic impact, for papers by Michel Tarpin Breakdown of academic impact, for papers by Midori Shimada Breakdown of academic impact, for papers by Salisha Hill Breakdown of academic impact, for papers by Elżbieta Speina Breakdown of academic impact, for papers by Juan I. Garaycoechea Breakdown of academic impact, for papers by Yuyin Li Breakdown of academic impact, for papers by Kin Chan Breakdown of academic impact, for papers by Elena Beltrami
Rankless by CCL
2026